Author： Russo Andrew F
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.8, Iss.7, 2007-07, pp. : 687-690
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
The Risk of Stroke in Patients with Migraine and Implications for Migraine Management
CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. :
Access to resources
Recommend
Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 4, 2012-12 ,pp. :
Heads up on botulinum toxin's use in migraine
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 560, 2008-01 ,pp. :
Central Sensitisation and Cutaneous Allodynia in Migraine: Implications for Treatment
By Landy S.
CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. :